Overview

A Trial of Nimotuzumab and Pinkiller Efficacy and Pain in Advanced Head and Neck Squamous Cell Carcinoma

Status:
ACTIVE_NOT_RECRUITING

Trial end date:
2025-04-14

Target enrollment:

Participant gender:

Summary

The purpose of this study is to investigate the impact of combining Nimotuzumab with analgesic agents on pain management outcomes, as well as the effectiveness and safety profile of this therapeutic combination in the comprehensive treatment of locally advanced head and neck squamous cell carcinoma.

Phase:

PHASE4

Details

Lead Sponsor:

Biotech Pharmaceutical Co., Ltd.

Collaborator:

Baotou Cancer Hospital

Treatments:

Cisplatin
nimotuzumab